Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation

Medicine and Dentistry

• Neoplasm 100%
• Protein P53 100%
• Gene Expression Profiling 100%
• Synapsin I 100%
• Protein Binding 100%
• Somatomedin B 100%
• Fibrolamellar Hepatocellular Carcinoma 100%
• Messenger RNA 100%
• RNA Sequencing 60%
• microRNA 40%
• Comparative Genomics 40%
• Gene Expression 20%
• Carcinogenesis 20%
• Metastatic Carcinoma 20%
• Recurrent Disease 20%
• Upregulation 20%
• Transcriptomics 20%
• Genomic Instability 20%
• Epidermal Growth Factor Receptor 20%
• Liver Tissue 20%
• Chromosome Analysis 20%
• Notch 20%
• Tumor 20%
• Rare Disease 20%
• Gene Product 20%
• Tumor Suppressor Protein 20%

Biochemistry, Genetics and Molecular Biology

• Binding Protein 100%
• Gene Expression Profiling 100%
• Synapsin I 100%
• P53 100%
• Insulin-Like Growth Factor 2 100%
• Messenger RNA 100%
• RNA Sequencing 75%
• MicroRNA 50%
• Comparative Genomics 50%
• Genomics 50%
• Genome Instability 25%
• Tumor Suppressor Protein 25%
• Gene Product 25%
• Notch 25%
• Transcriptomics 25%
• Gene Expression 25%
• Upregulation 25%
• Carcinogenesis 25%
• Epidermal Growth Factor Receptor 25%
• Rare Variant 25%
• Chromosome Analysis 25%

Immunology and Microbiology

• RNA Sequencing 100%
• Somatomedin B 100%
• Protein Binding 100%
• P53 100%
• Gene Expression Assay 100%
• Comparative Genomics 66%
• Notch 33%
• Genomic Instability 33%
• Gene Expression 33%
• Upregulation 33%
• Transcriptomics 33%
• Liver Tissue 33%
• Gene Product 33%